Thomas Meyer
Chief Executive Officer chez ALTAMIRA THERAPEUTICS LTD.
Fortune : 41 400 $ au 31/03/2024
Profil
Thomas Meyer is the founder of three companies.
Auris Medical Holding AG was founded in 1998, and Auris Medical AG and Altamira Therapeutics Ltd.
were both founded in 2003.
At Auris Medical AG, he holds the titles of Chairman & Chief Executive Officer, and at Altamira Therapeutics Ltd., he holds the title of Chairman & Chief Executive Officer.
Currently, Dr. Meyer holds multiple Chairman and Managing Director positions at Zilentin AG, Pharmatrail Ltd., Altamira Pharma GmbH, and Altamira Medica AG.
He previously held the position of Director & Deputy Chief Executive Officer at Disetronic Holding AG from 1999 to 2000.
Dr. Meyer earned a doctorate degree from the University of Fribourg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/03/2024 | 20 000 ( 1,27% ) | 41 400 $ | 31/03/2024 |
Postes actifs de Thomas Meyer
| Sociétés | Poste | Début |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Chief Executive Officer | 01/04/2003 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Chief Executive Officer | 23/07/2010 |
Altamira Pharma GmbH
 Altamira Pharma GmbH Pharmaceuticals: MajorHealth Technology Altamira Pharma GmbH manufactures pharmaceutical products. The private company is based in Zuchwil, Switzerland. The CEO of the Swiss company is Thomas Meyer. | Chief Executive Officer | - |
Zilentin AG
 Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Chairman | - |
Altamira Medica AG
 Altamira Medica AG Medical SpecialtiesHealth Technology Part of Altamira Therapeutics Ltd., Altamira Medica AG is a Swiss company that offers bentrio, an OTC drug-free nasal spray designed to protect against airborne allergens and viruses. The private company is based in Zug, Switzerland, and Thomas Meyer has been the CEO of the company since 2020. The spray forms a protective gel layer on the nasal mucosa to prevent contact with allergens or virus particles and helps to bind and discharge them. Altamira Medica strives to empower people to live with confidence and control when it comes to protection against allergens. | Chief Executive Officer | 01/09/2020 |
| Pharmatrail Ltd. | Chairman | - |
Anciens postes connus de Thomas Meyer
| Sociétés | Poste | Fin |
|---|---|---|
Auris Medical Holding AG /Old/
 Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Chief Executive Officer | - |
Disetronic Holding AG
 Disetronic Holding AG Medical SpecialtiesHealth Technology Disetronic Holding AG manufactured medical products for treatment of diabetes. The company infusion business was integrated into the Roche Diabetes Care Business Area within the Roche Diagnostics Division. Founded in 1990, the company was headquartered in Burgdorf, Switzerland. | Chief Executive Officer | - |
Formation de Thomas Meyer
| University of Fribourg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Disetronic Holding AG
Disetronic Holding AG Medical SpecialtiesHealth Technology Disetronic Holding AG manufactured medical products for treatment of diabetes. The company infusion business was integrated into the Roche Diabetes Care Business Area within the Roche Diagnostics Division. Founded in 1990, the company was headquartered in Burgdorf, Switzerland. | Health Technology |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Health Technology |
Altamira Pharma GmbH
Altamira Pharma GmbH Pharmaceuticals: MajorHealth Technology Altamira Pharma GmbH manufactures pharmaceutical products. The private company is based in Zuchwil, Switzerland. The CEO of the Swiss company is Thomas Meyer. | Health Technology |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
Altamira Medica AG
Altamira Medica AG Medical SpecialtiesHealth Technology Part of Altamira Therapeutics Ltd., Altamira Medica AG is a Swiss company that offers bentrio, an OTC drug-free nasal spray designed to protect against airborne allergens and viruses. The private company is based in Zug, Switzerland, and Thomas Meyer has been the CEO of the company since 2020. The spray forms a protective gel layer on the nasal mucosa to prevent contact with allergens or virus particles and helps to bind and discharge them. Altamira Medica strives to empower people to live with confidence and control when it comes to protection against allergens. | Health Technology |
| Pharmatrail Ltd. | |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
